These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 9152493)

  • 21. [The plasma antioxidant status and trace elements in patients with familial hypercholesterolemia treated with LDL-apheresis].
    Delattre J; Lepage S; Jaudon MC; Bruckert E; Assogba U; Bonnefont-Rousselot D
    Ann Pharm Fr; 1998; 56(1):18-25. PubMed ID: 9770031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is lipoprotein (a)-apheresis useful?
    Bambauer R
    Ther Apher Dial; 2005 Apr; 9(2):142-7. PubMed ID: 15828926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LDL-apheresis decreases plasma levels and urinary excretion of 8-epi-PGF2alpha.
    Oguogho A; Ferlitsch A; Sinzinger H
    Prostaglandins Leukot Essent Fatty Acids; 2000 Apr; 62(4):209-16. PubMed ID: 10882184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. One year experience with a low density lipoprotein apheresis system.
    Durst R; Rund D; Schurr D; Eliav O; Ben-Yehuda D; Shpizen S; Ben-Avi L; Schaap T; Pelz I; Leitersdorf E
    Isr Med Assoc J; 2002 Sep; 4(9):677-80. PubMed ID: 12440228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low-density lipoprotein-apheresis in two patients with extremely elevated lipoprotein (a) levels.
    Bambauer R; Schiel R; Klinkmann J; Latza R
    J Clin Apher; 1996; 11(2):78-80. PubMed ID: 8844436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low-density lipoprotein apheresis therapy with a direct hemoperfusion column: a Japanese multicenter clinical trial.
    Tasaki H; Yamashita K; Saito Y; Bujo H; Daida H; Mabuchi H; Tominaga Y; Matsuzaki M; Fukunari K; Nakazawa R; Tsuji M; Kawade Y; Yamamoto S; Ueda Y; Takayama K
    Ther Apher Dial; 2006 Feb; 10(1):32-41. PubMed ID: 16556134
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ghrelin and obestatin modulate early atherogenic processes on cells: enhancement of monocyte adhesion and oxidized low-density lipoprotein binding.
    Kellokoski E; Kunnari A; Jokela M; Mäkelä S; Kesäniemi YA; Hörkkö S
    Metabolism; 2009 Nov; 58(11):1572-80. PubMed ID: 19608205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of low-density lipoprotein apheresis on plasma matrix metalloproteinase-9 and serum tissue inhibitor of metalloproteinase-1 levels in diabetic hemodialysis patients with arteriosclerosis obliterans.
    Nakamura T; Matsuda T; Suzuki Y; Ueda Y; Koide H
    ASAIO J; 2003; 49(4):430-4. PubMed ID: 12918586
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Direct adsorption of low-density lipoprotein and lipoprotein(a) from whole blood: results of the first clinical long-term multicenter study using DALI apheresis.
    Bosch T; Lennertz A; Schenzle D; Dräger J;
    J Clin Apher; 2002; 17(4):161-9. PubMed ID: 12494408
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low-density lipoprotein apheresis by membrane differential filtration (cascade filtration) via arteriovenous fistula performed in children with familial hypercholesterolemia.
    Gülle S; Bak M; Serdaroglu E; Can D; Karabay O
    Ther Apher Dial; 2010 Feb; 14(1):87-92. PubMed ID: 20438523
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of simvastatin in familial hypercholesterolemia on the affinity of electronegative low-density lipoprotein subfractions to the low-density lipoprotein receptor.
    Benítez S; Ordóñez-Llanos J; Franco M; Marín C; Paz E; López-Miranda J; Otal C; Pérez-Jiménez F; Sánchez-Quesada JL
    Am J Cardiol; 2004 Feb; 93(4):414-20. PubMed ID: 14969613
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Different inflammatory responses induced by three LDL-lowering apheresis columns.
    Hovland A; Hardersen R; Sexton J; Mollnes TE; Lappegård KT
    J Clin Apher; 2009; 24(6):247-53. PubMed ID: 19927364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oxidizability of atherogenic low-density lipoprotein subspecies in severe familial hypercholesterolemia: impact of long-term low-density lipoprotein apheresis.
    Lepage S; Nigon F; Bonnefont-Rousselot D; Assogba U; Goulinet S; Chancharme L; Delattre J; Bruckert E; Chapman MJ
    J Cardiovasc Pharmacol Ther; 2000 Apr; 5(2):87-103. PubMed ID: 11150388
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LDL enhances monocyte adhesion to endothelial cells in vitro.
    Alderson LM; Endemann G; Lindsey S; Pronczuk A; Hoover RL; Hayes KC
    Am J Pathol; 1986 May; 123(2):334-42. PubMed ID: 3706494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasmapheresis in familial hypercholesterolemia.
    Thompson GR; Barbir M; Okabayashi K; Trayner I; Larkin S
    Arteriosclerosis; 1989; 9(1 Suppl):I152-7. PubMed ID: 2912429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decreased low-density lipoprotein oxidation after repeated selective apheresis in homozygous familial hypercholesterolemia.
    Napoli C; Ambrosio G; Scarpato N; Corso G; Palumbo G; D'Armiento FP; Mancini FP; Malorni A; Formisano S; Ruocco A; Calí A; Chiariello M
    Am Heart J; 1997 May; 133(5):585-95. PubMed ID: 9141382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complement profile and activation mechanisms by different LDL apheresis systems.
    Hovland A; Hardersen R; Nielsen EW; Enebakk T; Christiansen D; Ludviksen JK; Mollnes TE; Lappegård KT
    Acta Biomater; 2012 Jul; 8(6):2288-96. PubMed ID: 22373816
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of heparin-mediated extracorporeal low-density lipoprotein precipitation beyond lowering proatherogenic lipoproteins--reduction of circulating proinflammatory and procoagulatory markers.
    Wang Y; Blessing F; Walli AK; Uberfuhr P; Fraunberger P; Seidel D
    Atherosclerosis; 2004 Jul; 175(1):145-50. PubMed ID: 15186959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of intracellular iron in the toxicity of oxidized low density lipoprotein to cultured endothelial cells.
    Kuzuya M; Naito M; Yamada K; Funaki C; Hayashi T; Asai K; Kuzuya F
    Biochem Int; 1990 Nov; 22(3):567-73. PubMed ID: 2076112
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of alpha tocopherol supplementation on monocyte function. Decreased lipid oxidation, interleukin 1 beta secretion, and monocyte adhesion to endothelium.
    Devaraj S; Li D; Jialal I
    J Clin Invest; 1996 Aug; 98(3):756-63. PubMed ID: 8698868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.